Dashboard
Manage Tickers

BCTX BriaCell Therapeutics Corp.

Nasdaq briacell.com


$ 11.30 $ 1.48 (15.06 %)    

Friday, 07-Nov-2025 15:59:51 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 11.31
$ 9.94
$ 9.51 x 2
$ 12.50 x 30
$ 9.94 - $ 11.55
$ 6.00 - $ 190.50
74,416
na
21.31M
$ 0.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-16-2025 07-31-2025 10-K
2 06-16-2025 04-30-2025 10-Q
3 03-12-2025 01-31-2025 10-Q
4 12-16-2024 10-31-2024 10-Q
5 10-28-2024 07-31-2024 10-K
6 06-14-2024 04-30-2024 10-Q
7 03-18-2024 01-31-2024 10-Q
8 12-14-2023 10-31-2023 10-Q
9 10-25-2023 07-31-2023 10-K
10 06-14-2023 04-30-2023 10-Q
11 03-16-2023 01-31-2023 10-Q
12 12-14-2022 10-31-2022 10-Q
13 10-28-2022 07-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
BriaCell Therapeutics Presents Evidence Of...
11/07/2025 12:37:55

Next generation Bria-OTS+ platform demonstrates rapid, potent and durable anti-cancer activity by activating both innate and ad...

Core News & Articles
BriaCell To Present Preclinical Data On Ne...
11/04/2025 12:36:09

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ))) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-s...

the-independent-data-safety-monitoring-board-has-issued-its-fourth-consecutive-positive-recommendation-following-review-of-safety-data-from-briacell-therapeutics-phase-3-study-of-bria-imt-plus-an-immune-checkpoint-inhibitor-for-metastatic-breast-cancer
The Independent Data Safety Monitoring Boa...
10/22/2025 11:36:42

Following its review, the DSMB raised no safety concerns and recommended that the study continue without modifications. DSMB me...

Core News & Articles
BriaCell Therapeutics Adds Major Cancer Ce...
10/21/2025 11:56:49

79 clinical sites across 23 US states are currently enrolling patients in BriaCell's pivotal Phase 3 study in metastatic br...

briacell-therapeutics-collaborates-with-msk-cancer-centers-therapeutics-accelerator-cohort-program-to-accelerate-clinical-development-of-bria-ots-for-multiple-cancer-indications
BriaCell Therapeutics Collaborates With MS...
10/21/2025 11:39:43

Collaboration with MSK's Therapeutics Accelerator Program includes manufacturing, IND and clinical development support of t...

Core News & Articles
BriaCell Therapeutics Announces Clinical B...
10/20/2025 11:33:41

Biomarkers identified in BriaCell's Phase 2 study are showing similar and encouraging trends in the ongoing pivotal Phase 3...

Core News & Articles
BriaCell to Present Phase 3 Biomarker Data...
10/13/2025 11:34:01

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ))) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-s...

Core News & Articles
BriaCell Therapeutics To Present Preclinic...
10/03/2025 11:37:25

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ))) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-s...

hc-wainwright--co-maintains-buy-on-briacell-therapeutics-raises-price-target-to-40
HC Wainwright & Co. Maintains Buy on BriaC...
08/27/2025 10:12:22

HC Wainwright & Co. analyst Emily Bodnar maintains BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and raises the price t...

briacell-publishes-breakthrough-cancer-immunotherapy-research-in-jci-insight-journal
BriaCell Publishes Breakthrough Cancer Imm...
08/26/2025 11:35:41

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ)), (TSX:BCT) ("BriaCell" or the "Company"), a clinical-s...

briacell-wins-2m-grant-from-national-cancer-institute-to-advance-bria-pros-prostate-cancer-immunotherapy
BriaCell Wins $2M Grant From National Canc...
08/25/2025 11:39:05

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
08/22/2025 23:50:05

Core News & Articles
BriaCell Announces 1-for-10 Share Consolid...
08/21/2025 16:02:37

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ))) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-s...

briacell-joins-msks-2025-therapeutics-accelerator-to-fast-track-cancer-immunotherapy
BriaCell Joins MSK's 2025 Therapeutics Acc...
08/13/2025 11:36:00

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ)), (TSX:BCT) ("BriaCell" or the "Company"), a clinical-s...

briacell-granted-new-zealand-patent-for-its-whole-cell-technology-titled-whole-cell-cancer-vaccines-and-methods-for-selection-thereof
BriaCell Granted New Zealand Patent For It...
07/30/2025 11:31:57

Core News & Articles
BriaCell Unveils TILsRx Platform Aiming To...
07/29/2025 11:34:57

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW, BCTXZ))), (TSX:BCT) ("BriaCell"), a clinical-stage biotechnology compa...

briacell-announces-two-clinical-data-poster-presentations-at-esmo-2025-annual-meeting-highlighting-briaabc-phaseiii-trials
Briacell Announces Two Clinical Data Poste...
07/25/2025 11:33:45

briacell-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--54
BriaCell Therapeutics Shares Halted On Cir...
07/15/2025 19:13:18

briacell-therapeutics-shares-resume-trade
BriaCell Therapeutics Shares Resume Trade
07/15/2025 19:12:40

briacell-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--307
BriaCell Therapeutics Shares Halted On Cir...
07/15/2025 19:07:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION